Lipoprotein(a) and peripheral atherosclerosis in older adults.

[1]  J. Steurer,et al.  [Relative risk and odds ratio]. , 1997, Praxis.

[2]  J. Ordovás,et al.  Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. , 1994, JAMA.

[3]  L. Kuller,et al.  Blood Pressure Treatment Slows the Progression of Carotid Stenosis in Patients With Isolated Systolic Hypertension , 1994, Stroke.

[4]  M. L. Snyder,et al.  Polymorphic forms of Lp(a) with different structural and functional properties: cold-induced self-association and binding to fibrin and lysine-Sepharose. , 1994, Chemistry and physics of lipids.

[5]  S. Marcovina,et al.  Standardization of Lp(a) measurements. , 1994, Chemistry and physics of lipids.

[6]  P. Ridker,et al.  A prospective study of lipoprotein(a) and the risk of myocardial infarction. , 1993, JAMA.

[7]  P. Savage,et al.  Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[8]  A. Sharrett,et al.  Lipoprotein[a] as a risk factor for preclinical atherosclerosis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[9]  J. Loscalzo,et al.  Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation. , 1993, Biochemistry.

[10]  Y. Friedlander,et al.  Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo study. , 1993, Atherosclerosis.

[11]  A. Jovicić,et al.  Lipoprotein(a) in patients with carotid atherosclerosis and ischemic cerebrovascular disorders. , 1993, Atherosclerosis.

[12]  J. Douglas,et al.  Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. , 1992, The American journal of cardiology.

[13]  R. Klein,et al.  Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. , 1992, Metabolism: clinical and experimental.

[14]  S. Kelsey,et al.  Measurement Variability in Duplex Scan Assessment of Carotid Atherosclerosis , 1992, Stroke.

[15]  J. Huttunen,et al.  Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. , 1991, Atherosclerosis.

[16]  S. Srinivasan,et al.  Racial (Black‐White) Differences in Serum Lipoprotein (a) Distribution and Its Relation to Parental Myocardial Infarction in Children: Bogalusa Heart Study , 1991, Circulation.

[17]  L. Levitsky,et al.  Lipoprotein(a) Levels in Black and White Children and Adolescents With IDDM , 1991, Diabetes Care.

[18]  L. Wilhelmsen,et al.  Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. , 1990, BMJ.

[19]  J. Loscalzo,et al.  Lipoprotein(a). A unique risk factor for atherothrombotic disease. , 1990, Arteriosclerosis.

[20]  A. Scanu,et al.  Lipoprotein (a). Heterogeneity and biological relevance. , 1990, The Journal of clinical investigation.

[21]  M. Debakey,et al.  Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation. , 1989, Arteriosclerosis.

[22]  M. Dietel,et al.  Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. , 1989, Arteriosclerosis.

[23]  H. A. Kahn,et al.  Statistical Methods in Epidemiology , 1989 .

[24]  J. Breslow,et al.  Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis , 1989, Nature.

[25]  A. Scanu,et al.  A potential basis for the thrombotic risks associated with lipoprotein(a) , 1989, Nature.

[26]  G. Dahlén,et al.  Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. , 1989, European heart journal.

[27]  Scanu Am.  Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis. , 1988 .

[28]  G. Hoefler,et al.  Lipoprotein Lp(a): A Risk Factor for Myocardial Infarction , 1988, Arteriosclerosis.

[29]  G. Beck,et al.  Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. , 1988, Circulation.

[30]  L. Hunt,et al.  APOLIPOPROTEINS (a), AI, AND B AND PARENTAL HISTORY IN MEN WITH EARLY ONSET ISCHAEMIC HEART DISEASE , 1988, The Lancet.

[31]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[32]  J. Goldstein,et al.  Teaching old dogmas new tricks , 1987, Nature.

[33]  G. Jürgens,et al.  Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. , 1987, Neurology.

[34]  N. Morton,et al.  Lp(a) lipoprotein as a risk factor for myocardial infarction. , 1986, JAMA.

[35]  A. Gotto,et al.  CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .

[36]  K. Pfeiffer,et al.  Lipoprotein(a) as a strong indicator for cerebrovascular disease. , 1986, Stroke.

[37]  E. Barrett-Connor,et al.  The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. , 1985, Circulation.

[38]  C E Metz,et al.  Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. , 1982, Surgery.

[39]  B. Keagy,et al.  A quantitative method for the evaluation of spectral analysis patterns in carotid artery stenosis. , 1982, Ultrasound in medicine & biology.

[40]  D J Phillips,et al.  Carotid Artery Velocity Patterns in Normal and Stenotic Vessels , 1980, Stroke.

[41]  J M Reid,et al.  Quantitation of Carotid Stenosis with Continuous‐Wave (C‐W) Doppler Ultrasound , 1979, Stroke.

[42]  J. Albers,et al.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. , 1978, Journal of lipid research.

[43]  K. Walton,et al.  A study of methods of identification and estimation of Lp(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis. , 1974, Atherosclerosis.

[44]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[45]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[46]  K. Walton.  Distribution of Lipoproteins in Arteries and Tissue as Determined by Immunohistological and Radioactive Tracer Methods , 1972 .

[47]  K. Berg.  A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM. , 2009, Acta pathologica et microbiologica Scandinavica.

[48]  H. Peeters.  Protides of the Biological Fluids , 1958 .